Back

Zilver PTX post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in Japan: 24-month results

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Peripheral interventions Percutaneous / endovascular treatment ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Hiroyoshi Yokoi

Fukuoka Sanno Hospital, Fukuoka (Japan)

19 More presentations in this session

Presentation thumbnail
The difference of clinical factors on patency after endovascular therapy for femoropopliteal lesions between stent implantation and balloon angioplasty
Doctor S. Hiramori (Kitakyushu, JP)
Abstract Slides
Presentation thumbnail
Clinical outcomes of endovascular therapy for patients with critical hand ischemia
Doctor Y. Tomoi (Kitakyushu, JP)
Abstract Slides
Presentation thumbnail
Revascularization by endovascular treatment restores peripheral sensory disturbance in patients with critical limb ischemia
Doctor E. Shibahashi (Tokyo, JP)
Abstract
Presentation thumbnail
Optimal antithrombotic therapy for patient with an indication for long term oral anticoagulation undergoing femoropopliteal stenting.
Doctor K. Makino (Yokohama, JP)
Abstract
Presentation thumbnail
A comparison of combined balloon expandable and self-expandable nitinol stent vs double self-expandable nitinol stents for long aorto-iliac disease.
Doctor Y. Takeji (Kanazawa, JP)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Peripheral interventions

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources